Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular effects of high dose insulin therapy
2017-002553-11Phase 2Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Jul 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of human insulin in poisoning by agents primarily affecting the cardiovascular system (2 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Change in cardiac output from baseline. Started Jul 2017; status: completed.
02
Drugs
human insulin
03
Conditions
poisoning by agents primarily affecting the cardiovascular system
Beyond the preview
Go deeper on 2017-002553-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002553-11.